APA (7th ed.) Citation

CM, O., & J, S. (2017). Evaluation of the risk of liver damage from the use of 5-aminolevulinic acid for intra-operative identification and resection in patients with malignant gliomas. Acta neurochirurgica, 159(1), 145. https://doi.org/10.1007/s00701-016-3014-y

Chicago Style (17th ed.) Citation

CM, Offersen, and Skjoeth-Rasmussen J. "Evaluation of the Risk of Liver Damage from the Use of 5-aminolevulinic Acid for Intra-operative Identification and Resection in Patients with Malignant Gliomas." Acta Neurochirurgica 159, no. 1 (2017): 145. https://doi.org/10.1007/s00701-016-3014-y.

MLA (9th ed.) Citation

CM, Offersen, and Skjoeth-Rasmussen J. "Evaluation of the Risk of Liver Damage from the Use of 5-aminolevulinic Acid for Intra-operative Identification and Resection in Patients with Malignant Gliomas." Acta Neurochirurgica, vol. 159, no. 1, 2017, p. 145, https://doi.org/10.1007/s00701-016-3014-y.